Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-10-2
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0141-9854
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
317-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12358895-Adult, pubmed-meshheading:12358895-Amphotericin B, pubmed-meshheading:12358895-Antifungal Agents, pubmed-meshheading:12358895-Aspergillosis, pubmed-meshheading:12358895-Child, pubmed-meshheading:12358895-Cost-Benefit Analysis, pubmed-meshheading:12358895-Drug Costs, pubmed-meshheading:12358895-England, pubmed-meshheading:12358895-Humans, pubmed-meshheading:12358895-Liposomes, pubmed-meshheading:12358895-Liver Transplantation, pubmed-meshheading:12358895-Lung Diseases, Fungal, pubmed-meshheading:12358895-Medical Audit, pubmed-meshheading:12358895-Mycoses, pubmed-meshheading:12358895-Neutropenia, pubmed-meshheading:12358895-Organizational Policy, pubmed-meshheading:12358895-Postoperative Complications, pubmed-meshheading:12358895-Sinusitis, pubmed-meshheading:12358895-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Cost-effective use of liposomal amphotericin B.
pubmed:publicationType
Letter